ARDENT HEALTH INC (ARDT:NYSE)
$9.26 -0.24 (-2.5263%)
Analysed ARDENT HEALTH INC (ARDT:NYSE) News Sources
Ardent Health and Fujifilm Partner to Deliver Synapse Enterprise Imaging Across Radiology and Cardiology Throughout All Facilities
14-05-2026
yahoo.com
Ardent Health Appoints Dave Caspers as CEO
02-06-2026
yahoo.com
New Ardent Health CEO inherits growth ambitions
03-06-2026
healthcaredive.com
Ardent Health to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
03-06-2026
yahoo.com
BofA lifts UnitedHealth to Buy, says Q2 trend data sets up strong risk/reward
04-06-2026
yahoo.com
Wellvana Announces CARE Award Winners at 2026 Accountable Care Symposium
04-06-2026
yahoo.com
A Look At Ardent Health (ARDT) Valuation As New CEO Dave Caspers Takes The Helm
07-06-2026
yahoo.com
Will Ardent Health’s (ARDT) New CEO Shift the Focus of Its Post-IPO Efficiency Narrative?
07-06-2026
yahoo.com
Spotlight On Undervalued Small Caps With Insider Activity In June 2026
10-06-2026
yahoo.com
Is Ardent Health Stock a Buy After a Director Purchased More Than 11,000 Shares?
12-06-2026
fool.com
What is the current price of ARDENT HEALTH INC (ARDT:NYSE)?
The current price of ARDENT HEALTH INC (ARDT:NYSE) is $9.26.
ARDENT HEALTH INC (ARDT:NYSE) absolute price change since previous trading day?
The absolute price change of ARDENT HEALTH INC (ARDT:NYSE) since the previous trading day is $-0.24.
ARDENT HEALTH INC (ARDT:NYSE) percentage price change since previous trading day?
The percentage price change of ARDENT HEALTH INC (ARDT:NYSE) since the previous trading day is -2.5263%.
What is the most recent average sentiment score for ARDENT HEALTH INC (ARDT:NYSE)?
The most recent average sentiment score for ARDENT HEALTH INC (ARDT:NYSE) is 79 out of 100.
What is the most recent average sentiment for ARDENT HEALTH INC (ARDT:NYSE)?
The most recent sentiment for ARDENT HEALTH INC (ARDT:NYSE) is .
SEC-8K** Filing Available For ARDENT HEALTH INC (ARDT:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.